Organizers: Dorin Panescu, Chair, Technical Committee on Therapeutic Systems and Technologies, IEEE

Wednesday, August 30, 2006: 1.00 PM - 4.15 PM

Speakers:
Industry Panelists:
Dr. Rahul Mehra – Scientist, Medtronic. Member of the TC-TST.
Dr. Mark Kroll - Prolific inventor, co-founder of start-ups.
Dr. Reese Terry - Co-founder of Cyberonics. Member of the TC-TST.

Academia Panelists:
Dr. John Pearce – University of Texas at Austin. Member TC-TST.
Dr. Yongmin Kim – Chair, Department of Bioengineering, University of Washington, Seattle.
Dr. Nitish Thakor – The Johns Hopkins School of Medicine

Intellectual Property Attorney:
Steven Mitchell – Associate General Counsel, St. Jude Medical, Cardiac Rhythm Management.

Member of the VC Community:
Dr. Mudit K. Jain - Corporate Director, Johnson & Johnson Development Corp.

Abstract:
A Panel of members of the Academia and Industry communities will discuss topics related to:
- Medical device new product development
- Technology and product idea generation process
- Venture capital (VC) funding, process and sources
- Intellectual property (IP) joint development and sharing between Industry and Academia
- Technology licensing process
- Role of IEEE-EMBS in optimizing Industry-Academia collaboration

The first session, Medical device development: An industry-academia joint venture ?, will focus on the potential for new medical device development in academic centers as well as in industrial settings. This session will cover aspects related to product development, idea generation and sharing, VC funding and IP processes.

The second session, Can EMBS play a role in optimizing key aspects of industry-academia interaction? will discuss how the Medical Device Industry can participate in EMB Annual Conferences in a way that can better benefit members of the academic and industrial communities. The panel will also address items related Biomedical Engineering Departments curricula.

The Panel includes prominent members from industry and academia. An experienced IP attorney will address IP issues that are frequently raised by industry-academia interactions. Completing the Panel, an experienced member of the VC investment community will discuss items related to idea and new product development funding.